Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03029780 |
|---|---|
| Brief Title: | An Investigational Immuno-Therapy Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Renal Cell Carcinoma (CheckMate 800) |
| First Submitted : | January 20, 2017 |
| First Submitted that Met QC Criteria : | January 20, 2017 |
| First Posted : | January 24, 2017 (Estimate) |
| Results First Submitted : | November 27, 2018 |
| Results First Submitted that Met QC Criteria : | November 27, 2018 |
| Results First Posted : | December 19, 2018 |
| Last Update Submitted that Met QC Criteria : | November 27, 2018 |
| Last Update Posted : | December 19, 2018 |